💊 How can we secure the development and availability of new antibiotics?

On Sept. 24, the Parliamentary Group against #AMR discussed new EU incentives, including TEVs and subscription models, and Germany’s role in their implementation.

👉 Read more: t1p.de/sijt8

#Antibiotics #HealthPolicy

🦠 #INCATE, co-founded by #DZIF, awards Swiss start-up #PhalconBio €250,000 to advance preclinical development of an inhaled phage therapy for ventilator-associated pneumonia.

👉 Read more: t1p.de/0agp5

#AMR #PhageTherapy @incate.bsky.social

🦠 Dietary fiber does not act alone in the microbiome: an HZI study led by DZIF researcher Prof. Till Strowig shows that the effect of plant-based carbohydrates on 𝘚𝘦𝘨𝘢𝘵𝘦𝘭𝘭𝘢 𝘤𝘰𝘱𝘳𝘪 also depends on which bacteria are already present in the gut.
👉 t1p.de/j5eqx
@helmholtzhzi.bsky.social @embl.org

🦠 A clearer picture of microbial communities: Metax, a new taxonomic profiler developed at #HZI with #DZIF scientists, improves the reliable detection of microbial signatures.

👉 Read more: t1p.de/jjnqy

#Microbiome #Microbiology @helmholtzhzi.bsky.social

A new way to target drug-resistant #tuberculosis: An international team including #DZIF scientists has shown how the natural compound #corramycin targets DNA gyrase and why it remains effective against fluoroquinolone-resistant bacteria.

👉 Read more: t1p.de/t7m2a

#TB #DrugDevelopment

Interesting read 🤓👇 The PROTON project, led by #DZIF scientist Mark Brönstrup, is substantially supported by the #DZIF and its Product Development Unit 🥳

How can personalized #phage therapy be applied safely and consistently in clinical practice? A new #guideline covers key aspects like phage selection, quality control and clinical use. 👉 t1p.de/kocwc
@dgfi-org.bsky.social #DZIF @awmf.bsky.social @uniklinikkoeln.bsky.social @goetheuni.bsky.social

🥳Congratulations to Prof. Dr. Dr. Philipp Schommers for receiving the ERC Starting Grant! He works in the DZIF's #HIV Research Area. The prized project aims to significantly improve the treatment of #lymphomas.

👉Read more: t1p.de/6evuc

@uniklinikkoeln.bsky.social @erc.europa.eu

🎉🔬 Congratulations to Dr. Lutz Gieselmann on receiving the Robert Koch Foundation’s Postdoctoral Award in Immunology! His research led to the discovery of new broadly neutralizing antibodies against HIV-1.

👉 Read more: t1p.de/qtz94

#HIV #Research #Immunology @uniklinikkoeln.bsky.social

☕️ Take a break and join the next DZG Lunchtime Career Talk!
Meet Alba Sulaj (Heidelberg University Hospital) and hear how she combines patient care, translational research, and mentoring the next generation of clinician-scientists.

📅 Sept 10, 2026 | 13:00-14:00
🖥️ Online: lnkd.in/dxYPrr7X

For any tools to counter epidemics we need products in the market. Here is a precedent for how to accelerate market access for diagnostic products through collaboration.

www.charite.de/en/research/...

www.thelancet.com/journals/lan...

HZI-Forscher Mark Brönstrup und sein Team entwickeln einen Wirkstoff, der ein Toxin von S. aureus neutralisiert. So schaffen sie eine neue Behandlungsstrategie gegen bakterielle Infektionen. Das Projekt ist nun für den "Innovationspreis Niedersachsen" nominiert worden. Herzlichen Glückwunsch! #AMR